Products- Pharmaceutical Intermediates - Intermediate Antineoplastic

Cas No. Product Name  Other Name Assay
114915-14-9 (aR,bS)-beta-[[(1,1-Dimethylethoxy)carbonyl]amino]-alpha-hydroxy-benzenepropanoic acid (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12- Docetaxel Intermediate 98.50%
196404-55-4 (4S,5R)-3-tert-Butoxycarbony-2-(4-anisyl)-4-phenyl-5-oxazolidinecarboxylic acid Docetaxel Intermediate 98.50%
183133-94-0 7,10-Dimethoxy-10-DAB III Cabazitaxel Intermediate 98.50%
32981-86-5 10-Deacetylbaccatin III Paclitaxel Intermediate 99%
949023-16-9 Paclitaxel Side Chain;(4S,5R)-3-Benzoyl-2-(4-methoxyphenyl)-4-phenyl-5-oxazolidinecarboxylic acid Paclitaxel Intermediate 98.50%
179324-87-9 (aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate Bortezomib Intermediate 98%
114457-94-2 N-(2-Pyrazinylcarbonyl)-L-phenylalanine Bortezomib Intermediate 98%
875573-66-3 (7a,17b)-7-(9-Bromononyl)-estra-1,3,5(10)-triene-3,17-diol 17-acetate Fulvtrant Intermediate 90%

Products under Patent are not for ultimate sale in the country where patent has not expired. All liability for violation of Patent laws will be to the account of the Purchaser.